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Abstract: We describe the clinical course and successful treatment of two cases of 
  methicillin-resistant Staphylococcus aureus (MRSA) keratitis. In case 1, MRSA keratitis occurred 
5 days after cataract extraction, associated with endophthalmitis; in case 2, diagnosis was made 
19 months after penetrating keratoplasty. Treatment in both cases consisted of topical fortified 
vancomycin and fortified bacitracin. A third topical antibiotic, polymyxin B-trimethoprim, 
was added to the therapeutic regimen in case 2, one month into the treatment. Oral doxycycline 
was prescribed to reduce collagenase activity and treat blepharitis. Mupirocin nasal   ointment 
and skin antiseptics were used to decrease and eliminate potential MRSA colonization. Topical 
prednisolone acetate 1% was applied conservatively to mitigate inflammation in both cases. 
In case 2, topical cyclosporine A was also used for similar purposes. Keratitis may have worsened 
while on these immune-modulating drops, especially in case 2, and eradication of infection may 
have been slowed. Eventually both patients achieved full resolution of infection. Duration of 
keratitis was 3 and 1.5 months, respectively. Polyantimicrobial therapy is effective in eradicat-
ing MRSA-related postoperative keratitis. Topical fortified vancomycin and fortified bacitracin 
were used in both cases, with a third topical antibiotic, polymyxin B-trimethoprim, also required 
in case 2. Oral doxycycline, nasal mupirocin, and antiseptic soap may be useful adjuncts in 
  management. Treatment time to achieve full resolution may be prolonged relative to other types 
of bacterial keratitis. Alterations in immune status may have lengthened the time of treatment. Our 
two patients were immune compromised and were also susceptible to endophthalmitis. It is pos-
sible that topical immune-modulating drops such as prednisolone acetate may potentiate MRSA 
infection, and if used, should be only done so with great caution.
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Introduction
Reports of ocular methicillin-resistant Staphylococcus aureus (MRSA) infections 
have been increasing in recent years as the prevalence of this organism increases.1,2 
Blomquist retrospectively examined all culture-positive cases of MRSA from a public 
health care system over a 4-year period, finding that 1.3% had an ocular source.2 In their 
analysis of MRSA isolates from the Proctor clinical laboratory database, Freidlin 
et al determined that 14.6% of their ocular infections had a diagnosis of keratitis.3 
However, to date, there have been relatively few reports describing a precise treatment 
approach to MRSA-related keratitis.2–5 Herein, we report two cases of postoperative Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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MRSA keratitis, one after cataract surgery and one after 
corneal transplant. The medical records of these two patients 
were retrospectively reviewed. Data extraction included age, 
gender, medical history and risk factors for infection, eye 
culture results, antimicrobial susceptibilities, and treatment 
regimen. The clinical course and our therapeutic regimen 
are detailed.
Case 1
A 52-year-old male with multiple medical problems, 
including uncontrolled type 1 diabetes mellitus, chronic 
ischemic cardiomyopathy, and hypertension, as well as a 
number of emergency room and hospital admissions in the 
previous year, underwent uncomplicated cataract extrac-
tion of the right eye. On postoperative day 5, experiencing 
progressively worsening vision and pain, the patient was 
diagnosed with endophthalmitis. Concurrently, the patient 
was noted to have a 1.5 × 1 mm corneal infiltrate in the 
surgical paracentesis site (Figure 1). Vitreous cultures grew 
MRSA, which showed additional resistance to ampicillin-
sulbactam,   cefazolin, ciprofloxacin, clindamycin, levofloxa-
cin,   oxacillin, and   penicillin. Topical fortified vancomycin 
25 mg/mL and tobramycin 14 mg/mL drops were started 
on an hourly basis, while postoperative   prednisolone 
acetate 1% was continued four times per day. The patient 
also received intravitreal injections of ceftazidime and 
  vancomycin. Additional injections of vancomycin were 
required on two subsequent occasions when the endophthal-
mitis appeared to flare. By postoperative day 15, the corneal 
infiltrate had increased in size to 2 × 1.75 mm, with a larger 
hypopyon. The tobramycin drops were discontinued, and 
replaced with fortified bacitracin 3000 U/mL; vancomycin 
was increased in concentration to 50 mg/mL. As adjunctive 
therapy, mupirocin calcium nasal ointment was prescribed 
twice a day for five days to decrease the potential for MRSA 
  colonization, and doxycycline 100 mg orally twice a day 
was added to treat blepharitis. The patient was instructed 
to use an ethyl alcohol instant hand sanitizer several times 
daily. He seemed to show slight improvement, but one 
month postoperatively the infiltrate remained active, and 
there was a small new hypopyon. Although there was no 
growth on repeat corneal cultures, the patient neverthe-
less was started on a third topical antibiotic, polymyxin 
B-trimethoprim, at an initial dosing interval of every two 
hours. Prednisolone acetate was decreased to twice daily. On 
this regimen the infiltrate slowly improved and   ultimately 
resolved. The duration of the entire keratitis treatment 
totaled 3 months. The patient’s blood sugar was not well 
controlled during the period of infection, and was often 
above 140 mg/dL and even 200 mg/dL on one occasion.
Case 2
A 75-year-old female with multiple myeloma underwent 
cataract extraction in the right eye, complicated by a post-
operative corneal ulcer and endophthalmitis. No etiologic 
agent was identified at the time, but the condition resolved 
with broad spectrum antibiotic therapy.   Subsequently she 
underwent penetrating keratoplasty in the right eye for 
postinfectious corneal scarring. Nineteen months later, the 
patient was diagnosed with a corneal rejection. She was 
started on hourly topical prednisolone acetate 1%. Five 
days later, experiencing increased pain, she was found to 
have a suture abscess (Figure 2). The suture was removed, 
and the patient was started on topical levofloxacin 1.5% 
every 30 minutes. Prednisolone acetate 1% was reduced to 
once per day. Hourly topical fortified vancomycin 50 mg/
mL was added when cultures were positive for S. aureus. 
Several days later, when substantial corneal thinning was 
observed, prednisolone acetate was discontinued entirely, 
cyanoacrylate glue applied, and oral doxycycline 50 mg 
twice daily prescribed. After antimicrobial susceptibil-
ity testing revealed resistance to methicillin as well as to 
levofloxacin, erythromycin, and oxacillin, the fluoroqui-
nolone drops were replaced with topical fortified bacitracin 
3000 U/mL. Despite initial improvement, after two weeks 
of treatment, the infiltrate began to appear a little denser as 
topical antibiotics were gradually tapered. The cornea was 
recultured and this time coagulase-negative Staphylococ-
cus capitus was grown. Vancomycin and bacitracin were 
increased to greater frequency, resulting in lessening of the 
infiltrate again. At week 3 of treatment, topical cyclosporine 
Figure  1  slit  lamp  photograph  on  postoperative  day  10  showing  keratitis  and 
endophthalmitis. 
Note: Arrow points to infiltrate at paracentesis incision site.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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A 0.5% was started four times daily for residual stromal 
inflammation, which was still present. One week later, 
there appeared to be further worsening of the infiltrate, 
necessitating another increase in the frequency of topi-
cal treatment. Doxycycline was also increased to 100 mg 
by mouth twice a day to mitigate inflammation and treat 
underlying blepharitis. The patient was given nasal mupi-
rocin two times a day for 5 days, and instructed to wash her 
hands and body with chlorhexidine gluconate 4% soap, with 
the thought of decreasing possible sources of pathogenic 
  Staphylococci. On this regimen, the ulcer gradually healed 
with a stromal scar, and antibiotics were finally discontinued. 
The duration of treatment was 1.5 months.
Discussion
Detailed descriptions of ocular MRSA infections, specifi-
cally keratitis, have been somewhat limited in the literature. 
Shanmuganathan et al from the UK reported on four patients 
with MRSA keratitis treated with topical chloramphenicol.4 
The infections were noted to be nondestructive, with only 
mild superficial corneal involvement. In another report of 
two cases, MRSA keratitis was similarly found to be mild 
and slowly progressive, with superficial round infiltrates.5 
Topical vancomycin 2.5% was effective for therapy. Chiang 
and Rapuano detailed a case of MRSA keratitis that fol-
lowed cataract surgery.6 Despite treatment with high-dose 
vancomycin, the infection recurred twice over 6 months, and 
ultimately required lamellar keratectomy and a conjunctival 
flap. Cosar et al reported on two corneal MRSA infections 
after cataract surgery that resolved after 60 days and 108 days, 
respectively.7 There have been several reports of MRSA 
infection after refractive surgery.8–12 Moshirfar et al presented 
a case of MRSA keratitis after laser in situ keratomileusis, 
which was resistant to fourth-generation fluoroquinolones.8 
This patient required surgery to help effect a cure. Solomon 
et al appear to have the largest series of MRSA keratitis cases 
following laser refractive surgery, with their series of 13 eyes 
in 12 patients from multiple centers.9 They recommended 
initial treatment for postrefractive patients with a fourth-
generation fluoroquinolone every 30 minutes, alternating 
with fortified vancomycin 50 mg/mL every 30 minutes, as 
well as discontinuing topical steroid use.12
Our two cases of postoperative keratitis are similar 
to some of the foregoing postoperative reports in that the 
clinical presentation was severe, being associated with 
concurrent endophthalmitis in case 1 and keratolysis requir-
ing corneal gluing in case 2. S. aureus in each of the cases 
demonstrated multiple antimicrobial resistance, including 
to   fluoroquinolones. We have described our approach to the 
successful eradication of these two MRSA infections. Topical 
antibiotic therapy was the mainstay of treatment. Fortified 
vancomycin 50 mg/mL and fortified bacitracin 3000 U/mL 
were utilized in both cases after antimicrobial suscepti-
bility test results were obtained. A third topical antibiotic, 
polymyxin B-trimethoprim, was added one month into the 
treatment of case 1, when the infection appeared to have 
flared up and worsened. Oral doxycycline was prescribed to 
reduce corneal collagenase activity, reduce inflammation, 
and treat coexistent blepharitis. Mupirocin calcium ointment 
was applied twice daily to the nares for 5 days, and skin 
antiseptics were also used, with the intention of decreasing 
or eliminating potential sources of MRSA.
Although our patients were not specifically tested for 
MRSA colonization, they were considered to have a higher 
risk due to their relatively compromised immune status. 
Type 1 diabetes mellitus is known to be a strong risk factor for 
MRSA colonization and infection.13 Similarly, patients with 
multiple myeloma have decreased immunity to S. aureus, and 
may be susceptible to MRSA.14,15 Furthermore, in case 2, the 
patient’s previous endophthalmitis, current MRSA corneal 
infection, and subsequent culture positivity for coagulase-
negative Staphylococcus, well into the treatment, all sug-
gested that she might be a carrier for pathogenic bacteria, 
and in particular, resistant Staphylococci.16 One retrospec-
tive study at a university hospital found that up to two-
thirds of all patients with clinical MRSA infections had 
nasal   colonization.17 Another study examining only MRSA 
skin and soft tissue infections found that 37% of patients 
were colonized by MRSA.18 Despite our empiric approach 
described above, it is probably worthwhile in general to 
confirm MRSA colonization and thereby guide therapy by 
culturing sites such as the eyelids and nares.9,12
Figure 2 Slit lamp photo showing ulcer and infiltrate in corneal graft, after removal 
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Both of our MRSA cases required prolonged treatment 
relative to other forms of bacterial keratitis, with slow resolu-
tion only after 3 and 1.5 months, respectively. This extended 
clinical course was similar to the experience of some groups, 
but also notably longer than some other cases that have been 
reported.6,7,9 The relatively compromised immunity of our 
patients may have been a factor in prolonging the response 
to treatment. Another factor may have been the use of topical 
immune-modulating eyedrops. Prednisolone acetate 1% was 
given conservatively in order to moderate inflammation from 
endophthalmitis in case 1, and in case 2 to avert immunologic 
rejection. Topical cyclosporine A was also administered to the 
second patient during the latter part of her therapeutic course 
to counteract corneal inflammation. Without the means of 
direct comparison, it is unclear whether topical steroids 
and cyclosporine A in low dose have either a beneficial or 
detrimental influence on the clinical course. Nevertheless, 
certainly in case 2, it appears that use of these topical agents 
coincided with exacerbations of   infection. Relative immune 
compromise likely played a role in generally increasing these 
patients’ susceptibility to MRSA   infection. Endophthalmitis 
additionally complicated the clinical course of both. Ques-
tions for future study may include whether immune status 
affects response to and duration of treatment, whether or 
not patients with MRSA keratitis may have greater suscep-
tibility to endophthalmitis, and the role, if any, of topical 
corticosteroids.
Conclusion
The optimal approach to managing MRSA keratitis has not 
yet been determined. Polyantimicrobial therapy appears 
effective in eradicating MRSA-related postoperative 
  keratitis. Topical fortified antibiotics, ie, vancomycin 50 
mg/mL and topical fortified bacitracin 50 mg/mL, were 
used to treat both patients in the two case reports, with a 
third topical   antibiotic, polymyxin B-trimethoprim, added 
later for the   second patient. Oral doxycycline, mupirocin 
nasal ointment, and skin antiseptics were also used, and 
may be useful adjuncts in the management of this chal-
lenging condition. Full resolution of MRSA keratitis may 
require prolonged medical therapy in comparison with 
other forms of bacterial keratitis. Although the virulence 
of the pathogen certainly may be one factor, there may also 
be immunological factors at play as well. Patients in our 
study had underlying immunologic   compromise, and were 
susceptible to postoperative endophthalmitis. Topical pred-
nisolone acetate 1% and topical cyclosporine A 0.5% were 
also utilized to decrease inflammation during the treatment 
course. There is some indication that these medications may 
have contributed to lengthening the time needed to achieve 
clinical resolution. Based on this experience, we believe 
that topical immune-modulating medications should either 
not be used during the treatment of MRSA keratitis, or only 
used with appropriate caution.
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